Prevention of intra-abdominal adhesions using the antiangiogenic COX-2 inhibitor celecoxib.
Cahill
Ronan A
RA
D000005:Abdomen; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D004195:Disease Models, Animal; D007415:Intestinal Obstruction / Q000517:prevention & control*; D051379:Mice; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D000267:Tissue Adhesions / Q000517:prevention & control
D020533:Angiogenesis Inhibitors; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib